18 Chapter 1 41. Holland, T.L., A.S. Bayer, and V.G. Fowler, Persistent Methicilin-Resistant Staphylococcus aureus Bacteremia: Resetting the Clock for Optimal Management. Clin Infect Dis, 2022. 75(9): p. 1668-1674. 42. Tong, S.Y., et al., Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev, 2015. 28(3): p. 603-61. 43. Smit, J., et al., Gender differences in the outcome of community-acquired Staphylococcus aureus bacteraemia: a historical population-based cohort study. Clin Microbiol Infect, 2017. 23(1): p. 27-32. 44. Mansur, N., et al., Does sex affect 30-day mortality in Staphylococcus aureus bacteremia? Gend Med, 2012. 9(6): p. 463-70. 45. Forsblom, E., et al., Comparison of patient characteristics, clinical management, infectious specialist consultation, and outcome in men and women with methicillin-sensitive Staphylococcus aureus bacteremia: a propensity-score adjusted retrospective study. Infection, 2018. 46(6): p. 837-845. 46. Kang, C.K., et al., Gender affects prognosis of methicillin-resistant Staphylococcus aureus bacteremia differently depending on the severity of underlying disease. Eur J Clin Microbiol Infect Dis, 2018. 37(6): p. 1119-1123.
RkJQdWJsaXNoZXIy MTk4NDMw